Study on the Role of Polymers in Preventing the Crystallization of Roxadustat in an Aqueous Environment

[1]  C. Luebbert,et al.  Insights into influence mechanism of polymeric excipients on dissolution of drug formulations: A molecular interaction‐based theoretical model analysis and prediction , 2021, AIChE Journal.

[2]  T. Lodge,et al.  Role of Polymer Excipients in the Kinetic Stabilization of Drug-Rich Nanoparticles. , 2020, ACS applied bio materials.

[3]  L. S. Taylor,et al.  Congruent release of drug and polymer from amorphous solid dispersions: insights into the role of drug-polymer hydrogen bonding, surface crystallization and glass transition. , 2020, Molecular pharmaceutics.

[4]  T. Rades,et al.  Poorly soluble drugs. , 2020, International journal of pharmaceutics.

[5]  Bicheng Liu,et al.  Treatment of Renal Anemia with Roxadustat: Advantages and Achievement , 2020, Kidney Diseases.

[6]  J. Huwyler,et al.  Mechanisms of increased bioavailability through amorphous solid dispersions: a review , 2019, Drug delivery.

[7]  Geoff G. Z. Zhang,et al.  Impact of Monomeric versus Micellar Surfactant and Surfactant–Polymer Interactions on Nucleation–Induction Times of Atazanavir from Supersaturated Solutions , 2020 .

[8]  A. Sangamwar,et al.  Insights on role of polymers in precipitation of celecoxib from supersaturated solutions as assessed by focused beam reflectance measurement (FBRM). , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  C. Strachan,et al.  Direct Measurement of Amorphous Solubility , 2019, Analytical chemistry.

[10]  D. Ouyang,et al.  Investigating molecular interactions of high‐loaded glipizide‐HPMCAS microparticles by integrated experimental and modeling techniques , 2019, European Journal of Pharmaceutical Sciences.

[11]  Sohita Dhillon.  Roxadustat: First Global Approval , 2019, Drugs.

[12]  A. Bansal,et al.  Influence of Drug-Polymer Interactions on Dissolution of Thermodynamically Highly Unstable Cocrystal. , 2018, Molecular pharmaceutics.

[13]  Huijun Chen,et al.  Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment. , 2018, Molecular pharmaceutics.

[14]  T. Higashi,et al.  Identification of molecular‐interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy , 2018, International journal of pharmaceutics.

[15]  K. Kachrimanis,et al.  Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery , 2018, Pharmaceutics.

[16]  R. Williams,et al.  Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update. , 2018, International journal of pharmaceutics.

[17]  K. Becker,et al.  A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat , 2017, Advances in Therapy.

[18]  Niall J. O'Reilly,et al.  Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Shrawan Baghel,et al.  Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. , 2016, Journal of pharmaceutical sciences.

[20]  A. Krebs-Brown,et al.  Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor , 2016, Clinical Drug Investigation.

[21]  T. Rades,et al.  Recent advances in co-amorphous drug formulations. , 2016, Advanced drug delivery reviews.

[22]  S. Sotthivirat,et al.  Application of in vitro transmucosal permeability, dose number, and maximum absorbable dose for biopharmaceutics assessment during early drug development for intraoral delivery. , 2016, International journal of pharmaceutics.

[23]  Huai Sun,et al.  COMPASS II: extended coverage for polymer and drug-like molecule databases , 2016, Journal of Molecular Modeling.

[24]  Seamus D. Jones,et al.  Deconstructing HPMCAS: Excipient Design to Tailor Polymer-Drug Interactions for Oral Drug Delivery. , 2015, ACS biomaterials science & engineering.

[25]  M. Hussain,et al.  Impact of polymers on the precipitation behavior of highly supersaturated aqueous danazol solutions. , 2014, Molecular pharmaceutics.

[26]  T. Rades,et al.  Refining stability and dissolution rate of amorphous drug formulations , 2014, Expert opinion on drug delivery.

[27]  Ping I. Lee,et al.  Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation. , 2013, Molecular pharmaceutics.

[28]  L. S. Taylor,et al.  Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times , 2013 .

[29]  E. Kwong,et al.  Identification of suitable formulations for high dose oral studies in rats using in vitro solubility measurements, the maximum absorbable dose model, and historical data sets. , 2012, Molecular pharmaceutics.

[30]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[31]  Ashwini Nangia,et al.  Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals , 2011 .

[32]  A. Bansal,et al.  A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.